GlassScriptPhysician profile
Cindel Harris
NPI 1538655519
$1,080.29
in general payments reported to CMS, 2019-2025
10 companies · $555 in 2025
The $555 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $301 · 2024: $224 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $508.27 | 2023-2025 | Citrefix, Augment Injectable, N/A |
| Smith+Nephew, INC. | $204.83 | 2023-2025 | Grafix Pl, Renasys Touch, Stravix Pl |
| Amgen INC. | $120.29 | 2024 | Krystexxa |
| Abbvie INC. | $66.99 | 2023-2024 | |
| Treace Medical Concepts, INC. | $62.21 | 2025 | |
| Organogenesis INC. | $37.92 | 2025 | Apligraf |
| Orthofix Medical, INC. | $21.23 | 2024 | Physio-Stim |
| Convatec INC. | $21.20 | 2025 | |
| Ani Pharmaceuticals, INC. | $20.41 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $16.94 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindel Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.